"IDF Diabetes. 8th ed. Brussels: International Diabetes Federation.," http://diabetesatlas.org/IDF_Diabetes_Atlas_8e_interactive_EN/.

R. Donnelly, A. M. Emslie-Smith, I. D. Gardner, and A. D. Morris, "Vascular complications of diabetes," BMJ 320(7241), 1062–1066 (2000).

F. Henschen, "On the term diabetes in the works of Aretaeus and Galen.," Med. Hist. 13(2), 190–192 (1969).

C. Stylianou and C. Kelnar, "The introduction of successful treatment of diabetes mellitus with insulin," J. R. Soc. Med. 102(7), 298–303 (2009).

N. Moodley, U. Ngxamngxa, M. J. Turzyniecka, and T. S. Pillay, "Historical perspectives in clinical pathology: a history of glucose measurement," J. Clin. Pathol. 68(4), 258–264 (2015).

R. D. Cheeley and S. M. Joyce, "A clinical comparison of the performance of four blood glucose reagent strips," Am. J. Emerg. Med. 8(1), 11–15 (1990).

S. F. Clarke and J. R. Foster, "A history of blood glucose meters and their role in self-monitoring of diabetes mellitus," Br. J. Biomed. Sci. 69(2), 83–93 (2012).

L. A. Scrimgeour, B. A. Potz, F. W. Sellke, and M. R. Abid, "Continuous Glucose Monitoring in the Cardiac ICU: Current Use and Future Directions," Clin. Med. Res. 6(6), 173–176 (2017).

M. Sinha, K. M. McKeon, S. Parker, L. G. Goergen, H. Zheng, F. H. El-Khatib, and S. J. Russell, "A Comparison of Time Delay in Three Continuous Glucose Monitors for Adolescents and Adults," J. Diabetes Sci. Technol. 11(6), 1132–1137 (2017).

J. Kropff, P. Choudhary, S. Neupane, K. Barnard, S. C. Bain, C. Kapitza, T. Forst, M. Link, A. Dehennis, and J. H. DeVries, "Accuracy and Longevity of an Implantable Continuous Glucose Sensor in the PRECISE Study: A 180-Day, Prospective, Multicenter, Pivotal Trial," Diabetes Care 40(1), 63–68 (2017).

L. Heinemann and G. Freckmann, "CGM Versus FGM; or, Continuous Glucose Monitoring Is Not Flash Glucose Monitoring," J. Diabetes Sci. Technol. 9(5), 947–950 (2015).

T. Bailey, B. W. Bode, M. P. Christiansen, L. J. Klaff, and S. Alva, "The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System," Diabetes Technol. Ther. 17(11), 787–794 (2015).

"SUMMARY OF SAFETY AND EFFECTIVENESS DATA. FreeStyle Libre Flash Glucose Monitoring System," https://www.accessdata.fda.gov/cdrh_docs/pdf16/P160030B.pdf.

C. for D. and R. Health, "Recently-Approved Devices - Freestyle Libre 14 Day Flash Glucose Monitoring System - P160030/S017," https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/Recently-ApprovedDevices/ucm614903.htm.

C. for D. and R. Health, "Recently-Approved Devices - Minimed 670G System - P160017/S031," https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/Recently-ApprovedDevices/ucm614616.htm.

H. Thabit, L. Leelarathna, M. E. Wilinska, D. Elleri, J. M. Allen, A. Lubina-Solomon, E. Walkinshaw, M. Stadler, P. Choudhary, J. K. Mader, S. Dellweg, C. Benesch, T. R. Pieber, S. Arnolds, S. R. Heller, S. A. Amiel, D. Dunger, M. L. Evans, and R. Hovorka, "Accuracy of Continuous Glucose Monitoring During Three Closed-Loop Home Studies Under Free-Living Conditions," Diabetes Technol. Ther. 17(11), 801–807 (2015).

L. Bally, H. Thabit, S. Hartnell, E. Andereggen, Y. Ruan, M. E. Wilinska, M. L. Evans, M. M. Wertli, A. P. Coll, C. Stettler, and R. Hovorka, "Closed-Loop Insulin Delivery for Glycemic Control in Noncritical Care.," (2018).

D. Rodbard, "Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes," Diabetes Technol. Ther. 19(Suppl 3), S-25-S-37 (2017).

R. M. Bergenstal, S. Garg, S. A. Weinzimer, B. A. Buckingham, B. W. Bode, W. V. Tamborlane, and F. R. Kaufman, "Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes," JAMA 316(13), 1407–1408 (2016).

S. K. Garg, S. A. Weinzimer, W. V. Tamborlane, B. A. Buckingham, B. W. Bode, T. S. Bailey, R. L. Brazg, J. Ilany, R. H. Slover, S. M. Anderson, R. M. Bergenstal, B. Grosman, A. Roy, T. L. Cordero, J. Shin, S. W. Lee, and F. R. Kaufman, "Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes," Diabetes Technol. Ther. 19(3), 155–163 (2017).